3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 2/3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms
1
Melanoma
1
Locally Advanced Rectal Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
8
Radiotherapy
6
Fluorouracil
4
Paclitaxel
3
tislelizumab
2
nimotuzumab
2
Neoadjuvant Therapy
2
Esophagectomy
2
Drug Therapy
2
Capecitabine
2
spartalizumab
1
pembrolizumab
1
anlotinib
1
TP protocol
1
Surgical Procedures, Operative
1
Radiation
1
Oxaliplatin
1
Nivolumab
1
Leucovorin
1
Immunotherapy
1
Docetaxel
1
Clinical Trials, Phase II as Topic
1
Chemoradiotherapy
1
Cetuximab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Esophageal Squamous Cell Carcinoma
×
Immunotherapy
×
Clear all
NCT06907602
2025-04-02
ONTRESCC
Peking Union Medical College Hospital
Phase 2/3
Recruiting
120 enrolled